Cargando…

The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Feasibility Phase

PURPOSE: Chronic inflammation is integral to Myeloproliferative Neoplasm (MPN) pathogenesis. JAK inhibitors reduce cytokine levels, but not without significant side effects. Nutrition is a low-risk approach to reduce inflammation and ameliorate symptoms in MPN. We performed a randomized, parallel-ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mendez Luque, Laura F., Avelar-Barragan, Julio, Nguyen, Hellen, Nguyen, Jenny, Soyfer, Eli M., Liu, Jiarui, Chen, Jane H., Mehrotra, Nitya, Kosiorek, Heidi E., Dueck, Amylou, Himstead, Alexander, Heide, Elena, Lem, Melinda, Alaoui, Kenza El, Marin, Eduard Mas, Scherber, Robyn M., Mesa, Ruben A., Whiteson, Katrine L., Odegaard, Andrew, Fleischman, Angela G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197802/ https://www.ncbi.nlm.nih.gov/pubmed/37214789 http://dx.doi.org/10.1101/2023.05.09.23289740

Ejemplares similares

Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development
por: Geyer, Holly L., et al.
Publicado: (2015)

Fecal Microbial Community Composition in Myeloproliferative Neoplasm Patients Is Associated with an Inflammatory State
por: Oliver, Andrew, et al.
Publicado: (2022)

Online yoga in myeloproliferative neoplasm patients: results of a randomized pilot trial to inform future research
por: Huberty, Jennifer, et al.
Publicado: (2019)

The SIMM study: Survey of integrative medicine in myeloproliferative neoplasms
por: Gowin, Krisstina, et al.
Publicado: (2020)

Validation of a Modified Version of the Myeloproliferative Neoplasm Symptom Assessment Form Total Symptom Score
por: Langlais, Blake T., et al.
Publicado: (2021)

Depressive symptoms and myeloproliferative neoplasms: Understanding the confounding factor in a complex condition
por: Padrnos, Leslie, et al.
Publicado: (2020)

Analysis of Free-Text Responses in an International Myeloproliferative Neoplasms Patient Survey to Assess Impact of the COVID-19 Pandemic on Clinical Care
por: Langlais, Blake T., et al.
Publicado: (2020)

Myeloproliferative neoplasms – blurring the lines between cancer and chronic inflammatory disorder
por: Soyfer, Eli M., et al.
Publicado: (2023)

Tobacco use in the Myeloproliferative neoplasms: symptom burden, patient opinions, and care
por: Christensen, Sarah F., et al.
Publicado: (2021)

PB2174: DISSECTING THE MECHANISM OF INTERFERON ALFA (IFNΑ) RESPONSE IN MYELOPROLIFERATIVE NEOPLASM AND IDENTIFICATION OF PREDICTORS OF RESPONSE
por: Soyfer, Eli, et al.
Publicado: (2023)

The Critical Role of Inflammation in the Pathogenesis and Progression of Myeloid Malignancies
por: Craver, Brianna M., et al.
Publicado: (2018)

Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with my- eloproliferative neoplasms
por: Lee, Jaejun, et al.
Publicado: (2020)

Evaluation of Therapeutic Strategies to Reduce the Number of Thrombotic Events in Patients With Polycythemia Vera and Essential Thrombocythemia
por: Tremblay, Douglas, et al.
Publicado: (2021)

Quality of life and disease understanding: impact of attending a patient-centered cancer symposium
por: Padrnos, Leslie, et al.
Publicado: (2015)

Inflammation as a Driver of Clonal Evolution in Myeloproliferative Neoplasm
por: Fleischman, Angela G.
Publicado: (2015)

Body Mass Index and Total Symptom Burden in Myeloproliferative Neoplasms Discovery of a U-shaped Association
por: Christensen, Sarah Friis, et al.
Publicado: (2020)

Population‐level evidence of survival benefits of patient‐reported outcome symptom monitoring software systems in routine cancer care
por: Basch, Ethan, et al.
Publicado: (2020)

Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disorders
por: Mesa, Ruben A
Publicado: (2007)

Incidence of myeloproliferative neoplasms in Calgary, Alberta, Canada
por: Heppner, Jonathan, et al.
Publicado: (2019)

The SMAC mimetic LCL-161 selectively targets JAK2(V617F) mutant cells
por: Craver, Brianna M., et al.
Publicado: (2020)

Severe FMF Presentation with Rare Association of MEFV Variants (p.Pro369Ser/p.Glu148Gln)
por: El Alaoui, Kenza, et al.
Publicado: (2019)

Microbiome distinctions between the CRC carcinogenic pathways
por: DeDecker, Lauren, et al.
Publicado: (2021)

Patient reported symptoms associated with quality of life during chemo‐ or immunotherapy for bladder cancer patients with advanced disease
por: Taarnhøj, Gry A., et al.
Publicado: (2020)

Myeloproliferative neoplasms
por: Cross, Nick
Publicado: (2019)

Myeloproliferative neoplasms
por: Kiladjian, Jean-Jacques
Publicado: (2018)

Modifiable Lifestyle and Medical Risk Factors Associated With Myeloproliferative Neoplasms
por: Duncombe, Andrew S., et al.
Publicado: (2020)

Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
por: Person, Fermin, et al.
Publicado: (2021)

Perceptions of Myeloproliferative Neoplasm Patients Participating in an Online Yoga Intervention: A Qualitative Study
por: Huberty, Jennifer, et al.
Publicado: (2018)

Disruption of asxl1 results in myeloproliferative neoplasms in zebrafish
por: Gjini, Evisa, et al.
Publicado: (2019)

Physical Activity as a Nonpharmacological Symptom Management Approach in Myeloproliferative Neoplasms: Recommendations for Future Research
por: Eckert, Ryan, et al.
Publicado: (2016)

Safety of adjuvant CDK4/6 inhibitors during the COVID-19 pandemic
por: Pfeiler, Georg, et al.
Publicado: (2022)

Epigenetics in Myeloproliferative Neoplasms
por: McPherson, Suzanne, et al.
Publicado: (2017)

Immunotherapy in Myeloproliferative Diseases
por: Braun, Lukas M., et al.
Publicado: (2020)

Aetiology of Myeloproliferative Neoplasms
por: McMullin, Mary Frances, et al.
Publicado: (2020)

The microenvironment in myeloproliferative neoplasm
por: Méndez-Ferrer, Simón, et al.
Publicado: (2018)

Spleen in myeloproliferative neoplasms
por: Barosi, Giovanni
Publicado: (2018)

Epigenetics in myeloproliferative neoplasms
por: Greenfield, Graeme, et al.
Publicado: (2023)

Spontaneous Periodic Hypothermia with Confirmed Epilepsy: A Report of Two Cases
por: Rossignon, Pierre, et al.
Publicado: (2023)

Smartphone-Based Meditation for Myeloproliferative Neoplasm Patients: Feasibility Study to Inform Future Trials
por: Huberty, Jennifer, et al.
Publicado: (2019)

Associations Between Global Mental Health and Response to an App-Based Meditation Intervention in Myeloproliferative Neoplasm Patients
por: Puzia, Megan E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8tudcqovchc21pm9iunfkemm5i